BrainFx Ai Inc is improving clinical care and accelerating
neuroscience. neuroscience.
Learn how.
Therapeutics Development
Objectively demonstrate the cognitive safety and efficacy of your treatments with our non-invasive and cost-effective clinical endpoint.
Our product platform allows researchers to easily
monitor the cognitive health of study participants
throughout the clinical trial process. Determining the
cognitive safety of developmental drugs is integral to
improving patient outcomes and reducing commercial
risk.
Mitigate the risk of late-stage
failure by proactively monitoring cognitive signals
using our patient friendly and convenient assessment
tools that will integrate seamlessly into research
workflow.
Efficiency and Convenience
Assess participants in-person or remotely
Patient-directed assessments for monitoring in
between clinical visits
Detailed report generated immediately after
assessments
Different assessment options to suit your study and
participants
Comprehensive dashboard and normative data base to
enable robust data analytics
Data visualization via tailored graphs and charts
Our latest research
Working with the Mayo Clinic to understand
Long-COVID
This study focuses on understanding the neurological impact of Long-COVID by developing a solution that assists clinicians and researchers to better understand and address the impacts of this new and emerging phenomenon.
